Page 84 - Read Online

Sazonova et al. Vessel Plus 2019;3:8 I http://dx.doi.org/10.20517/2574-1209.2019.01 Page 7 of 7

2. Fraker TD Jr, Fihn SD; 2002 Chronic Stable Angina Writing Committee; American College of Cardiology; American Heart Association,
et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable
angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group
to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol
2007;50:2264-74.
3. Lazari J, Money-Kyrle A, Wakerley BR. Cardiac cephalalgia: severe, non-exertional headache presenting as unstable angina. Pract
Neurol 2018; doi: 10.1136/practneurol-2018-002045.
4. Fineschi M, D’Ascenzi F, Sirbu V, Mondillo S, Pierli C. Diagnosis and management of a patient with recurrent variant angina and
history of percutaneous coronary intervention: vasospasm and percutaneous coronary intervention. J Cardiovasc Med (Hagerstown)
2018;19:31-3.
5. Suhrs HE, Kristensen AM, Rask AB, Michelsen MM, Frestad D, et al. Coronary microvascular dysfunction is not associated with a
history of reproductive risk factors in women with angina pectoris-An iPOWER substudy. Maturitas 2018;107:110-15.
6. Guan XQ, Xue YJ, Wang J, Ma J, Li YC, et al. Low bone mineral density is associated with global coronary atherosclerotic plaque
burden in stable angina patients. Clin Interv Aging 2018;13:1475-83.
7. Abbasi M, Neishaboury M, Koohpayehzadeh J, Etemad K, Meysamie A, et al. National prevalence of self-reported coronary heart
disease and chronic stable angina pectoris: factor analysis of the underlying cardiometabolic risk factors in the SuRFNCD-2011. Glob
Heart 2018;13:73-82.e1.
8. Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, et al. Assessing the cost-effectiveness of type 1 diabetes interventions: the
Sheffield type 1 diabetes policy model. Diabet Med 2014;31:477-86.
9. Haberka M, Mizia-Stec K, Lasota B, Kyrcz-Krzemień S, Gąsior Z. Obesity and antiplatelet effects of acetylsalicylic acid and
clopidogrel in patients with stable angina pectoris after percutaneous coronary intervention. Pol Arch Med Wewn 2015;125:620-30.
10. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, et al. 2016 ESC guidelines for the diagnosis and treatment of acute
and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society
of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J
2016;37:2129-200.
11. Buchanan DM, Arnold SV, Gosch KL, Jones PG, Longmore LS, et al. Association of smoking status with angina and health-related
quality of life after acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2015;8:493-500.
12. Gaibazzi N. Stress echocardiography: need to optimize its appropriate use in suspected angina and a review of available additional tools
for its clinical application in 2018: first do no harm! second do it at the highest possible accuracy. J Cardiovasc Echogr 2018;28:154-9.
13. Sazonova MA. Association of mitochondrial genome mutations with lipofibrous plaques in human aortic intima. Patol Fiziol Eksp Ter
2015;59:17-28. (in Russian)
14. Sazonova M, Budnikov E, Khasanova Z, Sobenin I, Postnov A, et al. Studies of the human aortic intima by a direct quantitative assay of
mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204:184-90.
15. Sazonova MA, Sinyov VV, Ryzhkova AI, Galitsyna EV, Khasanova ZB, et al. Role of mitochondrial genome mutations in pathogenesis
of carotid atherosclerosis. Oxid Med Cell Longev 2017; 2017:6934394.
16. Sazonova MA, Sinyov VV, Barinova VA, Ryzhkova AI, Zhelankin AV, et al. Mosaicism of mitochondrial genetic variation in
atherosclerotic lesions of the human aorta. Biomed Res Int 2015;2015:825468.
17. Sazonova MA, Postnov AIu, Orekhov AN, Sobenin IA. A new method of quantitative estimation of mutant allele in mitochondrial
genome. Patol Fiziol Eksp Ter 2011;4:81-4. (in Russian)
18. Zbuk K, Xie C, Young R, Heydarpour M, Pare G, et al. BRCA2 variants and cardiovascular disease in a multi-ethnic study. BMC Med
Genet 2012;13:56.
19. Amosenko FA, Trubnikova IS, Zakhar’ev VM, Bannikov VM, Sazonova MA, et al. TUB9 polymorphism in the CFTR gene of cystic
fibrosis patients, carriers, and healthy donors from the Moscow region. SSCP and restriction analyses. Genetika 1997;33:257-61. (in
Russian)
20. Sazonova MA, Ryzhkova AI, Sinyov VV, Galitsyna EV, Orekhova VA, et al. New markers of atherosclerosis: a threshold level of
heteroplasmy in mtDNA mutations. Vessel Plus 2017;1:182-91.
21. Goji N, Mathews A, Huszczynski G, Laing CR, Gannon VP, et al. A new pyrosequencing assay for rapid detection and genotyping of
Shiga toxin, intimin and O157-specific rfbE genes of Escherichia coli. J Microbiol Methods 2015;109:167-79.
22. Alderborn A, Kristofferson A, Hammerling U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA
sequencing. Genome Res 2000;10:1249-58.
23. Amosenko FA, Sazonova MA, Kapranov NI, Trubnikova IS, Kalinin VN. Analysis of various polymorphic markers of the CFTR gene
in cystic fibrosis patients and healthy donors from the Moscow region. Russ J Genet 1995;31:457-9.
24. Sazonova MA, Amosenko FA, Kapranov NI, Kalinin VN. Molecular genetic analysis of TUB18 and TUB20 intragenic polymorphism
and various mutations of the CFTR gene in the Moscow region. Genetika 1997;33:1303-7. (in Russian)
25. Bilovol O. Predictors of hormonal and metabolic disorders of arterial hypertension and type 2 diabetes mellitus comorbidity. Vessel Plus
2017;1:22-8.
26. IBM SPSS software. Available from: https://www.ibm.com/analytics/us/en/technology/spss. [Last accessed on 11 Mar 2019].